Automated synthesis of [(18)F](2S,4R)-4-fluoroglutamine on a GE TRACERlab™ FX-N Pro module.

[1]  P. Massion,et al.  Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer , 2016, Molecular Imaging and Biology.

[2]  C. Brennan,et al.  Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo , 2015, Science Translational Medicine.

[3]  H. Kung,et al.  [18F](2S,4S)-4-(3-Fluoropropyl)glutamine as a Tumor Imaging Agent , 2014, Molecular pharmaceutics.

[4]  H. Kung,et al.  Comparative Evaluation of 18F-Labeled Glutamic Acid and Glutamine as Tumor Metabolic Imaging Agents , 2012, The Journal of Nuclear Medicine.

[5]  Wei Liu,et al.  Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC , 2012, Proceedings of the National Academy of Sciences.

[6]  L. Chodosh,et al.  PET Imaging of Glutaminolysis in Tumors by 18F-(2S,4R)4-Fluoroglutamine , 2011, The Journal of Nuclear Medicine.

[7]  Gregory Stephanopoulos,et al.  Molecular Systems Biology Peer Review Process File Oncogenic K-ras Decouples Glucose and Glutamine Metabolism to Support Cancer Cell Growth Transaction Report , 2022 .

[8]  H. Kung,et al.  Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors. , 2011, Journal of the American Chemical Society.

[9]  Yu Kyeong Kim,et al.  Highly efficient production of [(18)F]fallypride using small amounts of base concentration. , 2010, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[10]  C. Dang,et al.  Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. , 2010, Cancer cell.